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Abstract
Background: Prevalence and risk factors for Chlamydia trachomatis infection among young men in
Switzerland is still unknown. The objective of the present study was to assess prevalence and risk
factors for C. trachomatis infection in young Swiss men.
Methods: 517 young Swiss men were enrolled in this cross-sectional study during their
compulsory military recruitment. Participants completed a questionnaire and gave urine samples
which were screened for C. trachomatis DNA by PCR. Genotyping of positive samples was done by
amplification and sequencing the ompA gene.
Results: The prevalence of chlamydial infection among young Swiss male was 1.2% (95%
confidence interval [95%CI], 0.4–2.5%). C. trachomatis infection was only identified among the 306
men having multiple sexual partner. Although frequent, neither unprotected sex (absence of
condom use), nor alcohol and drug abuse were associated with chlamydial infection. Men living in
cities were more frequently infected (2.9%, 95%CI 0.8–7.4%) than men living in rural areas (0.5%,
95%CI 0.1–1.9%, p = 0.046). Moreover, naturalised Swiss citizens were more often positive (4.9%,
95%CI 1.3–12.5%) than native-born Swiss men (0.5%, 95%CI 0.1–1.7%, p = 0.003).
Conclusion: In comparison with other countries, the prevalence of chlamydial infection in men is
extremely low in Switzerland, despite a significant prevalence of risky sexual behaviour. C.
trachomatis infection was especially prevalent in men with multiple sexual partners. Further
research is required (i) to define which subgroup of the general population should be routinely
screened, and (ii) to test whether such a targeted screening strategy will be effective to reduce the
prevalence of chlamydial infection among this population.
Background
Chlamydia trachomatis infection is the commonest sexually
transmitted bacterial disease in European countries [1,2]
and in the United States [3,4]. Although the major impact
of disease is on the female genital tract [1,2], men may suf-
fer from urethritis, prostatitis, infertility and Reiter's syn-
drome [1].
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infection are related to sexual behaviour, i.e. early age of
first intercourse, multiple partners, and inconsistent con-
dom use [1]. Since most infections caused by C. trachom-
atis are asymptomatic, the establishment of screening
programs, as already done in some developed countries, is
necessary to control the disease [5].
The studies carried out in Europe on C. trachomatis infec-
tion among young males have shown high rates ranging
from 7.8–13.3%[1,6-11]. Similar prevalence were
observed in other developed (3.7–5.3% [4,12-14]) and
developing countries (3.1–7.9% [15,16]).
However, no data are available from Switzerland. The
present cross-sectional study is intended to determine the
prevalence of and risk factors for C. trachomatis infection
among young healthy Swiss males.
Methods
In this study approved by the ethical committee of the
University of Lausanne (n° 177/06), we included all 18–
26 years-old Swiss men who presented for their medical
entry examination at the Army Recruitment Centre of
Lausanne, Switzerland during winter 2006–2007 and
who gave written consent for urinary C. trachomatis
screening. The volunteers completed a questionnaire on
sociodemographic, sexual and behavioral risk factors. Our
questionnaire was adapted from questionnaires used in
previous published studies measuring sexually transmit-
ted infections [6,12,17-19]. Completion of the question-
naire was accurately done, since answers to similar and
complementary questions formulated in different ways
were 97% and 95% congruent for demographic questions
and for questions on their sexual activities, respectively.
DNA was extracted from centrifuged first-void urine and
analyzed by real-time Taqman PCR, as described [20].
This PCR exhibited an excellent analytical sensitivity of 1
copy per reaction, good intrarun and interrun reliability,
and a specificity of 100% when considering Cobas Ampli-
cor as gold standard [20]. Positive samples were then gen-
otyped using ompA sequencing [21]. Statistical analyses
were performed using STATA (College-Station, USA).
Confidence Intervals were calculated using the Daly
method [22].
Results
Among 521 eligible men, four did not complete the ques-
tionnaire and were excluded. The sociodemographic char-
acteristics of the 517 remaining volunteers are shown in
Table 1. The mean age was 20.6 years (standard deviation
± 1.4 years). A total of 87% of the participants reported
being sexually-experienced and 59.9% of the participants
reported having more than two sexual partners in their life
span. The consistent use of condoms for all sexual rela-
tions was reported by 32.3% of the 517 volunteers.
Among those with more than 4 partners (n = 178), 21.3%
regularly used condoms. While 67.9% of the study partic-
ipants drank alcohol at least every week-end, 3.5% drank
alcohol every day. Almost half (47.6%) of the participants
were cigarette smokers, and 28.1% of them smoke more
than 20 cigarettes per day. Occasional or daily cannabis
consumption was reported by 27.1% and 7.8% of the par-
ticipants, respectively. Ecstasy, heroin or cocaine have
been taken by 6.4% of the studied population.
The prevalence of chlamydial infection was 1.2% (95%CI
0.4–2.5%) among all 517 volunteers and of 1.3% (95%CI
0.3–2.4%) among the 450 sexually-experienced men. No
participants without or with only a single lifetime sexual
partner were diagnosed with chlamydial infection. Con-
versely, 1.9% (95%CI 0.7–4.2%) of those with multiple
sexual partners were C. trachomatis positive. Two men who
tested positive for Chlamydia reported having consistently
used condoms during all sexual relations. Among the 9
men who reported having had a male sexual partner, none
had a positive Chlamydia test. When considering only
Swiss born men, the prevalence was 0.5% (95%CI 0.2–
2.1%). Conversely, among foreign born naturalized men
who originated from Europe, the prevalence was 2.4%
(95CI 0.1–13.3%). For those originated from foreign
countries outside Europe, a prevalence of 7.5% (95%CI
1.5–21.9%) was observed. Young men living in cities
more than 10'000 inhabitants and/or earning more than
2000 SFrs (1600 US$) were at increased risk of C. tracho-
matis infection (Table 1). Alcohol, cigarette, cannabis and
illegal drug consumption were frequently recorded, but
were not associated with chlamydial infection. Chlamy-
dial serotypes were E (n = 3), J, Ia and D (n = 1 each).
Discussion
Our cross-sectional study provides, for the first time, prev-
alence data of C. trachomatis infection in young Swiss
men. In Switzerland, previous studies mainly focused on
women and evaluated highly selected study populations
[23]. A 2.8% prevalence was recorded among asympto-
matic sexually active Swiss women in 1998 [23]. How-
ever, studied women were mainly from urban area, where
the prevalence is higher. Moreover, age of first sexual
intercourse is lower for women or occur with older part-
ner [24], likely also contributing to increased prevalence
in women. C. trachomatis is a reportable disease in Swit-
zerland. Since 1999, there has been a significant increase
(64%) in the number of official reports of C. trachomatis
infection in Switzerland [25,26]. However, among the
517 asymptomatic young Swiss men we investigated, the
prevalence was only 1.2%. This Chlamydia prevalence is
much lower than that reported for young asymptomatic
males in Norway (7.8%)[6], Scotland (9.8%) [8] and the
entire UK (13.3%) [1]. In USA, prevalence is also higherPage 2 of 5
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Table 1: Chlamydia trachomatis prevalence according to various demographic and behavioural variables
Characteristics C. trachomatis negative (%) C. trachomatis positive (%) p-value* Odds Ratio 95% CI Prevalence of C. trachomatis Daly 95% CI
Total 511 98.8 6 1.2 1.2 0,4 – 2,5
Age (year ± SD) 20.6 + 1.4 20.7 + 2.7
≤ 20 276 54 5 83.3 0.23 ref 1.8 0.6 – 4.2
> 20 235 46 1 16.7 0.23 0,03 – 2,02 0.4 0 – 2.4
Nationality at birth
Switzerland 433 84.7 2 33.3 0.003 ref 0.5 0.1 – 1.7
Europe 41 8 1 16.7 5.3 0,47 – 59,5 2.4 0.1 – 13.3
Other 37 7.2 3 50 17.6 2,84 – 108 7.5 1.5 – 21.9
Place of residence
> 10'000 inhabitants 134 26.2 4 66.7 0.046 ref 2.9 0.8 – 7.4
< 10'000 inhabitants 377 73.8 2 33.3 0.17 0.03 – 0.98 0.5 0.1 – 1.9
Main occupation
Work 265 51.9 4 66.7 0.74 ref 1.5 0.4 – 3.8
Studies 231 45.2 2 33.3 0.53 0,1 – 2,69 0.9 0.1 – 3.1
Declined to respond 15 2.9 0 0 - - 0 0 – 20
Monthly income
< 1000 Frs. 301 58.9 1 16.7 0.064 ref 0.3 0 – 1.8
1000 – 2000 Frs. 69 13.5 1 16.7 4.4 0,3 – 70,6 1.4 0 – 8
> 2000 Frs. 112 21.9 4 66.7 10.8 1,2 – 97,2 3.5 0.9 – 8.8
Declined to respond 29 5.7 0 0 - - 0 0 – 10,3
Number of lifetime sexual partner
0 67 13.1 0 0 0.26 - - 0 0 – 4.5
1 125 24.5 0 0 - - 0 0 – 2,4
≥ 2 306 59.9 6 100 - - 1.9 0.7 – 4.2
Declined to respond 13 2.5 0 0 - - 0 0 – 23
Sexual orientation
heterosexual 386 75.5 4 66.7 0.66 ref 1 0.3 – 2.6
homo/bisexual 9 1.8 0 0 - - 0 0 – 33,3
Declined to respond 116 22.7 2 33.3 1.7 0,3 – 9,2 1.7 0.2 – 6.1
Condom use
Always 165 32.3 2 33.3 1 ref 1.2 0.1 – 4.3
Sometimes 238 46.6 3 50 1.04 0,17 – 6,29 1.2 0.3 – 3.6
Never 74 14.5 1 16.7 1.11 0,10 – 12,5 1.3 0 – 7.4
Declined to respond 34 6.7 0 0 - - 0 0 – 8.8
* Fisher's exact chi2
BMC Infectious Diseases 2008, 8:45 http://www.biomedcentral.com/1471-2334/8/45than that found in Switzerland, ranging from 3.7% [4] to
5.3% [13].
Multiple partners and inconsistent condom use are recog-
nised as important predictors of C. trachomatis infection
[1,6,16]. However, screening on the basis of condom use
would have missed a substantial number of infections in
the population we studied, since two of six infected men
reported having always used condoms. The effect or no
effect of condom use as a preventive mesure should ide-
ally be confirmed in a larger cohort. In our study, variables
associated with C. trachomatis infection were "multiple
sexual partners", "living in a large city" and "foreign born,
naturalized". The higher prevalence observed in the latter
subgroup, similar to that of other European and non-
European countries, demonstrate that the overall low
prevalence of 1.2% we observed was not due to a low sen-
sitivity of the PCR, but rather reflects a true local differ-
ence in prevalence. Serotype E was more prevalent in
Switzerland, as it is the case in other European countries
[21,27].
Conclusion
This is the first study of the prevalence of C. trachomatis
infection conducted in young Swiss males. Since military
service is compulsory for all Swiss men, the study popula-
tion we screened corresponds to an unselected and unbi-
ased representative sample of young healthy Swiss men.
Despite a prevalence of sexual risk behaviour which is
similar to that recorded in other countries [24], C. tracho-
matis prevalence in Swiss males is extremely low. In the
future, in order to identify populations with a high preva-
lence that may benefit from mass screening, it will be
important to more precisely identify risks factors associ-
ated with chlamydial infection.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
DB and GG initiated and designed the study, interpreted
the results. DB, CB and GG performed the statistical anal-
yses. DB and JPK were responsible for patient recruitment,
clinical assessment, data management and blood sam-
pling. KJ and GG did the laboratory analyses. The paper
was written by DB and GG, and reviewed by all other con-
tributors.
Acknowledgements
We thank all employees from the Recruitment Centre of the Swiss Army 
who were involved in this study. We particularly thank Cordula Equey and 
Manuela Bersier for help for sampling, André Baud for computer assistance, 
and Ana Palma for technical assistance. We also thank Philip E. Tarr and 
Anthony Staines (reviewer) for their critical review of the manuscript. Gil-
bert Greub is supported by the Leenards Foundation through a "Bourse 
Leenards pour la relève académique en médecine clinique à Lausanne".
References
1. Manavi K: A review on infection with Chlamydia trachomatis.
Best Pract Res Clin Obstet Gynaecol 2006, 20:941-951.
2. Fenton KA, Lowndes CM: Recent trends in the epidemiology of
sexually transmitted infections in the European Union.  Sex
Transm Infect 2004, 80:255-263.
3. Schillinger JA, Dunne EF, Chapin JB, Ellen JM, Gaydos CA, Willard NJ,
Kent CK, Marrazzo JM, Klausner JD, Rietmeijer CA, Markowitz LE:
Prevalence of Chlamydia trachomatis infection among men
screened in 4 U.S. cities.  Sex Transm Dis 2005, 32:74-77.
4. Miller WC, Ford CA, Morris M, Handcock MS, Schmitz JL, Hobbs
MM, Cohen MS, Harris KM, Udry JR: Prevalence of chlamydial
and gonococcal infections among young adults in the United
States.  JAMA 2004, 291:2229-2236.
5. Low N: Screening programmes for chlamydial infection:
when will we ever learn?  BMJ 2007, 334:725-728.
6. Bakken IJ, Skjeldestad FE, Halvorsen TF, Thomassen T, Storvold G,
Nordbo SA: Chlamydia trachomatis among young Norwegian
men: sexual behavior and genitourinary symptoms.  Sex
Transm Dis 2007, 34:245-249.
7. Wagenlehner FM, Weidner W, Naber KG: Chlamydial infections
in urology.  World J Urol 2006, 24:4-12.
8. McKay L, Clery H, Carrick-Anderson K, Hollis S, Scott G: Genital
Chlamydia trachomatis infection in a subgroup of young
men in the UK.  Lancet 2003, 361:1792.
9. Lamontagne DS, Fenton KA, Randall S, Anderson S, Carter P: Estab-
lishing the National Chlamydia Screening Programme in
England: results from the first full year of screening.  Sex
Transm Infect 2004, 80:335-341.
10. Kang M, Rochford A, Johnston V, Jackson J, Freedman E, Brown K,
Mindel A: Prevalence of Chlamydia trachomatis infection
among 'high risk' young people in New South Wales.  Sex
Health 2006, 3:253-254.
11. van der Snoek EM, Gotz HM, Mulder PG, Verkooyen RP, van der Mei-
jden WI: Prevalence of STD and HIV infections among
attenders of the Erasmus MC STD clinic, Rotterdam, The
Netherlands, during the years 1996 to 2000.  Int J STD AIDS
2003, 14:119-124.
12. Arcari CM, Gaydos JC, Howell MR, McKee KT, Gaydos CA: Feasi-
bility and short-term impact of linked education and urine
screening interventions for Chlamydia and gonorrhea in
male army recruits.  Sex Transm Dis 2004, 31:443-447.
13. Cecil JA, Howell MR, Tawes JJ, Gaydos JC, McKee KT Jr., Quinn TC,
Gaydos CA: Features of Chlamydia trachomatis and Neisseria
gonorrhoeae infection in male Army recruits.  J Infect Dis 2001,
184:1216-1219.
14. Scholes D, Heidrich FE, Yarbro P, Lindenbaum JE, Marrazzo JM: Pop-
ulation-Based Outreach for Chlamydia Screening in Men:
Results from a Randomized Trial.  Sex Transm Dis 2007.
15. Buve A, Weiss HA, Laga M, Van DE, Musonda R, Zekeng L, Kahindo
M, Anagonou S, Morison L, Robinson NJ, Hayes RJ: The epidemiol-
ogy of gonorrhoea, chlamydial infection and syphilis in four
African cities.  AIDS 2001, 15 Suppl 4:S79-S88.
16. Fioravante FC, Costa Alves MF, Guimaraes EM, Turchi MD, Freitas
HA, Domingos LT: Prevalence of Chlamydia trachomatis in
asymptomatic Brazilian military conscripts.  Sex Transm Dis
2005, 32:165-169.
17. Jennings JM, Luo RF, Lloyd LV, Gaydos C, Ellen JM, Rietmeijer CA:
Age-bridging among young, urban, heterosexual males with
asymptomatic Chlamydia trachomatis.  Sex Transm Infect 2006.
18. Marrazzo JM, Ellen JM, Kent C, Gaydos C, Chapin J, Dunne EF, Riet-
meijer CA: Acceptability of urine-based screening for Chlamy-
dia trachomatis to asymptomatic young men and their
providers.  Sex Transm Dis 2007, 34:147-153.
19. Fenton KA, Korovessis C, Johnson AM, McCadden A, McManus S,
Wellings K, Mercer CH, Carder C, Copas AJ, Nanchahal K, Macdow-
all W, Ridgway G, Field J, Erens B: Sexual behaviour in Britain:
reported sexually transmitted infections and prevalent geni-
tal Chlamydia trachomatis infection.  Lancet 2001,
358:1851-1854.Page 4 of 5
(page number not for citation purposes)
BMC Infectious Diseases 2008, 8:45 http://www.biomedcentral.com/1471-2334/8/45Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
20. Jaton K, Bille J, Greub G: A novel real-time PCR to detect
Chlamydia trachomatis in first-void urine or genital swabs.  J
Med Microbiol 2006, 55:1667-1674.
21. Lysen M, Osterlund A, Rubin CJ, Persson T, Persson I, Herrmann B:
Characterization of ompA genotypes by sequence analysis of
DNA from all detected cases of Chlamydia trachomatis
infections during 1 year of contact tracing in a Swedish
County.  J Clin Microbiol 2004, 42:1641-1647.
22. Daly L: Simple SAS macros for the calculation of exact bino-
mial and Poisson confidence limits.  Comput Biol Med 1992,
22:351-361.
23. Paget WJ, Zbinden R, Ritzler E, Zwahlen M, Lengeler C, Sturchler D,
Matter HC: National laboratory reports of Chlamydia tracho-
matis seriously underestimate the frequency of genital
chlamydial infections among women in Switzerland.  Sex
Transm Dis 2002, 29:715-720.
24. Wellings K, Collumbien M, Slaymaker E, Singh S, Hodges Z, Patel D,
Bajos N: Sexual behaviour in context: a global perspective.
Lancet 2006, 368:1706-1728.
25. Abraham S, Toutous-Trellu L, Pechere M, Hugonnet S, Liassine N,
Yerly S, Rohner P, Ninet B, Hirschel B, Piguet V: Increased inci-
dence of sexually transmitted infections in Geneva, Switzer-
land.  Dermatology 2006, 212:41-46.
26. Lautenschlager S: Sexually transmitted infections in Switzer-
land: return of the classics.  Dermatology 2005, 210:134-142.
27. Jonsdottir K, Kristjansson M, Hjaltalin OJ, Steingrimsson O: The
molecular epidemiology of genital Chlamydia trachomatis in
the greater Reykjavik area, Iceland.  Sex Transm Dis 2003,
30:249-256.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2334/8/45/prepubPage 5 of 5
(page number not for citation purposes)
